Order NO. D194016
产品描述
概述
CA19-9 is a serum tumor marker for pancreatic cancer diagnosis. It is also used for monitoring therapy in patients with pancreatic adenocarcinoma. CA19-9 is synthesized by normal pancreatic and biliary ductal cells and by gastric, colon, endometrial and saliva epithelia. In a normal patient, it is present in small amounts in serum. The plasmatic levels of CA19-9 are greatly increased in neoplastic disease.
应用
免疫检测,免疫组织化学(IHC)
属性
保存缓冲液 |
-20°C, 0.01M PBS (pH7.4), 0.15M NaCl. Avoid repeated freeze-thaw cycles.
|
运输条件 |
2-8°C
|
靶点全称 |
Cancer Antigen 19-9
|
靶点别名 |
Cancer Antigen 19-9; Carbohydrate Antigen 19-9; CA 19-9; CA19.9; sialylated Lewis a antigen; 癌抗原19-9; 糖链抗原19-9
|
靶点研究领域 |
Cardiovascular, Cancer
|
亚型 |
IgG1
|